A safety evaluation of an extrafine aerosol of beclomethasone dipropionate in 6161 patients using the UK SAMM guidelines
Beclomethasone dipropionate (BDP) is an established inhaled therapy for the management of asthma. BDP is commonly delivered via a pressurized metered-dose inhaler (MDI) using a chlorofluorocarbon (CFC) propellant system. A new extrafine aerosol of BDP (QVAR, 3M Pharmaceuticals) has been developed wh...
| Main Authors: | , , , , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado em: |
2002
|